PLoS ONE · 2014 · 101 citations · 40 references
MedicinePharmaceuticsPharmacologyClinical PharmacologyDrug DeliveryNeuropharmacologyBlood-brain Barrier PenetrationBlood-brain Barrier PharmacologyDrug DispositionTransporter PharmacologyBlood-brain Barrier Drug TransportBlood-brain Barrier ModelsBlood-brain Barrier PermeabilityBlood-brain Barrier Transport StudiesBrain PermeabilityCerebral Drug PenetrationDrug PermeabilityPharmacokinetics At The Blood-brain Barrier
The aim of this work was to conduct a comprehensive study about the transport properties of NSAIDs across the blood-brain barrier (BBB) in vitro. Transport studies with celecoxib, diclofenac, ibuprofen, meloxicam, piroxicam and tenoxicam were accomplished across Transwell models based on cell line PBMEC/C1-2, ECV304 or primary rat brain endothelial cells. Single as well as group substance studies were carried out. In group studies substance group compositions, transport medium and serum content were varied, transport inhibitors verapamil and probenecid were added. Resulted permeability coefficients were compared and normalized to internal standards diazepam and carboxyfluorescein. Transport rankings of NSAIDs across each model were obtained. Single substance studies showed similar rankings as corresponding group studies across PBMEC/C1-2 or ECV304 cell layers. Serum content, glioma conditioned medium and inhibitors probenecid and verapamil influenced resulted permeability significantly. Basic differences of transport properties of the investigated NSAIDs were similar comparing all three in vitro BBB models. Different substance combinations in the group studies and addition of probenecid and verapamil suggested that transporter proteins are involved in the transport of every tested NSAID. Results especially underlined the importance of same experimental conditions (transport medium, serum content, species origin, cell line) for proper data comparison.
40
The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence
Jorge I. Alvarez, Aurore Dodelet-Devillers, Hania Kébir et al. · Science · 2011 · 830 citations
Blood–brain barrier dysfunction in parkinsonian midbrain in vivo
Rudie Kortekaas, Klaus L. Leenders, Joost C.H. van Oostrom et al. · Annals of Neurology · 2005 · 725 citations
Azza A. K. El‐Sheikh, Jeroen J. M. W. van den Heuvel, Frans G. M. Rüssel · Journal of Pharmacology and Experimental Therapeutics · 2006 · 232 citations · Full text